Axsome Therapeutics, Inc. — Form D
Axsome Therapeutics, Inc. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2015-05-19. The offering totals $7.5M, of which $2.5M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2015-05-19
- Form: D
- Accession: 0001579428-15-000002
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $7.5M
- Amount sold: $2.5M
- Remaining: $5.0M
- Minimum investment: $25K
- Investors: 14
- Date of first sale: 2015-05-06
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-240209
Issuer
- Name: Axsome Therapeutics, Inc.
- CIK: 0001579428
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2012
- Address: 45 ROCKEFELLER PLAZA, 20th Floor, NEW YORK, NY, 10111
- Phone: 212-203-5072
Officers, directors & promoters (3)
| Name | Role | Location |
|---|
| Herriot Tabuteau | Director | New York, NY |
| Herriot Tabuteau | Executive Officer | New York, NY |
| Herriot Tabuteau | Promoter | New York, NY |
Other filings by this issuer (5)
More